For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Cullinan Therapeutics Inc (NASDAQ: CGEM) closed at $11.13 down -3.72% from its previous closing price of $11.56. In other words, the price has decreased by -$3.72 from its previous closing price. On the day, 0.35 million shares were traded. CGEM stock price reached its highest trading level at $11.81 during the session, while it also had its lowest trading level at $11.07.
Ratios:
For a deeper understanding of Cullinan Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 24.46 and its Current Ratio is at 24.46. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $30.
On May 01, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $40.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 06 ’25 when Michaelson Jennifer sold 4,000 shares for $12.51 per share. The transaction valued at 50,040 led to the insider holds 95,760 shares of the business.
JENNIFER MICHAELSON bought 8,000 shares of CGEM for $101,440 on Jan 06 ’25. On Dec 24 ’24, another insider, AHMED NADIM, who serves as the President and CEO of the company, sold 8,400 shares for $11.87 each. As a result, the insider received 99,708 and left with 263,150 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGEM now has a Market Capitalization of 648073216 and an Enterprise Value of 72441112.
Stock Price History:
Over the past 52 weeks, CGEM has reached a high of $30.19, while it has fallen to a 52-week low of $10.00. The 50-Day Moving Average of the stock is -16.98%, while the 200-Day Moving Average is calculated to be -36.85%.
Shares Statistics:
For the past three months, CGEM has traded an average of 506.95K shares per day and 505400 over the past ten days. A total of 58.14M shares are outstanding, with a floating share count of 36.82M. Insiders hold about 36.76% of the company’s shares, while institutions hold 77.34% stake in the company. Shares short for CGEM as of 1734048000 were 9652522 with a Short Ratio of 19.04, compared to 1731628800 on 8709252. Therefore, it implies a Short% of Shares Outstanding of 9652522 and a Short% of Float of 19.219998999999998.
